2015 American Transplant Congress
Predictors of Time to Recurrence and Mortality Associated With Recurrent Hepatocellular Carcinoma After Liver Transplantation
Transplantation, UCLA, Los Angeles, CA.
Background: While recurrent hepatocellular carcinoma (HCC) after liver transplantation (LT) portends a poor prognosis, adjuvant therapy may prolong survival. We sought to identify factors that…2015 American Transplant Congress
Geographic Variation in Listing Practices Represents Competetive Behaviors and Access to Care Rather Than Differences in Demand for Liver Transplantation
Purpose: This study evaluates whether program and patient demographics influence liver transplant listing practices.Methods:2013 liver waiting list and transplant (Tx) variables, US Census socioeconomic variables,…2015 American Transplant Congress
Sofosbuvir-Based Therapy for Hepatitis C Recurrence Post Liver Transplantation
Introduction:Sofosbuvir is approved to treat HCV infection in all genotypes with sustained virological response 12 weeks after completion of therapy (SVR12)rates of up to 100%.…2015 American Transplant Congress
Graft-Versus-Host Disease After Orthotopic Liver Transplantation: Multivariate Analysis of Risk Factors
Introduction:Acute graft versus host disease (GVHD) is a rare fatal complication following orthotopic liver transplantation (OLT). It involves activation of donor T lymphocytes by antigen…2015 American Transplant Congress
Native Kidney Biopsy Does Not Predict Post Liver Transplant Renal Outcomes
Liver transplant (LT) recipients are at high risk of posttransplant renal disease but the extent of renal disease is often unrecognized in the pretransplant setting.…2015 American Transplant Congress
MELD as a Predictor of Post-Transplant Survival
Department of Surgery, Johns Hopkins, Baltimore.
MELD is a reliable tool to predict liver waitlist mortality. Previous studies of MELD and post-transplant outcomes have had conflicting results.METHODS: We used generalized gamma…2015 American Transplant Congress
Comparison of Liver Transplant Outcomes for Recipients With MELD <35 Vs. >35
Div. of Transplantation, Department of Surgery, University of Minnesota, Mpls, MN.
Introduction: Current allocation favors liver recipients with MELD > 35 . We compared liver tx outcomes among two groups based on MELD score at the…2015 American Transplant Congress
Medication Adherence and Treatment Satisfaction in Liver Transplant Recipients
Background: Research has indicated that adherence to medication in patients with liver transplant is poor and considered as one of the main barriers to the…2015 American Transplant Congress
Characteristics and Outcomes of Patients With Incidental Hepatocellular Carcinoma Detected in the Explanted Liver Following Transplant
Introduction: Despite pre-operative cross-sectional imaging, incidental hepatocellular carcinoma (iHCC) is sometimes diagnosed upon histological examination of the liver explant following transplantation for another indication. Whilst…2015 American Transplant Congress
Replacement of Lamivudine By Telbivudine to Improve Renal Function for Post-Transplant Hepatitis B Patients – A Randomized Clinical Trial
Background: Lamivudine is one of the anti-hepatitis B virus (HBV) agents to prevent HBV recurrence after transplantation because lamivudine is safe for long-term use. However,…
American Transplant Congress abstracts